Conditions: Allergic Rhinitis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 69
Healthy volunteers: no

Brief summary:
The purpose of this study is to assess the safety and tolerability of montelukast 10 mg/loratadine 10 mg versus placebo in Mexican participants with allergic rhinitis.

Detailed description:

Arms:
arm 1: Montelukast 10 mg/loratadine 10 mg combination tablet administered orally once daily for 2 weeks arm 2: Matching placebo tablet administered orally once daily for 2 weeks

Interventions: intervention 1: Montelukast 10 mg/loratadine 10 mg intervention 2: Placebo
Intervention descriptions: intervention 1: Montelukast 10 mg/loratadine 10 mg tablet administered once daily intervention 2: Matching placebo tablet administered once daily

Protocol document: